| Trial ID: | L0301 |
| Source ID: | NCT00938561
|
| Associated Drug: |
Inulin
|
| Title: |
Evaluation of New Markers to Assess Kidney Function
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Inulin
|
| Outcome Measures: |
Primary: Accuracy and precision of the different markers for measuring GFR, End points are not applicable. It's a cross-sectional design study |
|
| Sponsor/Collaborators: |
Sponsor: Tufts Medical Center | Collaborators: Dialysis Clinic, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-09
|
| Completion Date: |
2011-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-07-13
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00938561
|
